Willa Ann Hsueh
#145,837
Most Influential Person Now
Researcher
Willa Ann Hsueh's AcademicInfluence.com Rankings
Willa Ann Hsuehcomputer-science Degrees
Computer Science
#7300
World Rank
#7688
Historical Rank
Artificial Intelligence
#2947
World Rank
#2992
Historical Rank
Database
#4361
World Rank
#4535
Historical Rank
Download Badge
Computer Science
Willa Ann Hsueh's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Willa Ann Hsueh Influential?
(Suggest an Edit or Addition)Willa Ann Hsueh's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. (2000) (1253)
- Synthetic LXR ligand inhibits the development of atherosclerosis in mice (2002) (946)
- Minireview: adiposity, inflammation, and atherogenesis. (2003) (777)
- Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. (1996) (526)
- Expression and Function of PPARγ in Rat and Human Vascular Smooth Muscle Cells (2000) (427)
- Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice (2001) (424)
- Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. (1999) (394)
- Obesity, Inflammation, and Cancer. (2016) (388)
- Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists (2012) (356)
- Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. (2013) (316)
- Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus (1998) (314)
- Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. (2003) (308)
- SPECIAL REPORT Preserving Renal Function in Adults With Hypertension and Diabetes: A Consensus Approach (2000) (292)
- Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. (2000) (288)
- Role of endothelial dysfunction in insulin resistance. (2003) (282)
- Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. (2005) (271)
- Coronary Circulatory Dysfunction in Insulin Resistance, Impaired Glucose Tolerance, and Type 2 Diabetes Mellitus (2005) (254)
- Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect. (1995) (247)
- Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. (1996) (242)
- Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. (1997) (234)
- Recipes for creating animal models of diabetic cardiovascular disease. (2007) (222)
- Angiotensin II, adhesion, and cardiac fibrosis. (2000) (219)
- PPARδ-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis (2008) (217)
- Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. (1987) (213)
- PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells. (1999) (193)
- Insulin signaling in the arterial wall. (1999) (191)
- Age-Accelerated Atherosclerosis Correlates With Failure to Upregulate Antioxidant Genes (2009) (190)
- Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Retinoblastoma Phosphorylation and G1 → S Transition in Vascular Smooth Muscle Cells* (2000) (190)
- Peroxisome Proliferator-Activated Receptor-γ Ligands Inhibit Choroidal Neovascularization (2000) (174)
- Coronary Vasomotor Abnormalities in Insulin-Resistant Individuals (2004) (172)
- Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes. (2001) (161)
- Cardiovascular risk continuum: implications of insulin resistance and diabetes. (1998) (159)
- Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. (1999) (159)
- TNF-α–Induced Migration of Vascular Smooth Muscle Cells Is MAPK Dependent (1999) (158)
- Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators. (2001) (156)
- PPARγ and Atherosclerosis (2001) (155)
- Expression and function of PPARgamma in rat and human vascular smooth muscle cells. (2000) (154)
- Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes (2006) (153)
- The Trans-Ancestral Genomic Architecture of Glycemic Traits (2020) (151)
- Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy. (2005) (146)
- Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes. (2000) (145)
- Myocardial osteopontin expression is associated with left ventricular hypertrophy. (1997) (144)
- TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. (2001) (144)
- Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease. (2003) (142)
- The clock gene, brain and muscle Arnt‐like 1, regulates adipogenesis via Wnt signaling pathway (2012) (138)
- Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart. (2004) (137)
- Endothelial-Dependent Vascular Effects of Insulin and Insulin-Like Growth Factor I in the Perfused Rat Mesenteric Artery and Aortic Ring (1994) (136)
- The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease. (2003) (135)
- C-Reactive Protein Induces Apoptosis in Human Coronary Vascular Smooth Muscle Cells (2004) (134)
- Angiotensin II causes mesangial cell hypertrophy. (1993) (127)
- Peroxisome Proliferator-Activated Receptor &ggr;: Implications for Cardiovascular Disease (2004) (126)
- CRTC3 links catecholamine signalling to energy balance (2010) (124)
- Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism. (1993) (124)
- Expression and Function of Peroxisome Proliferator–Activated Receptor-γ in Mesangial Cells (2001) (122)
- Lipoprotein lipase is a gene for insulin resistance in Mexican Americans. (2004) (117)
- Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells. (1996) (117)
- Human decidua is a major source of renin. (1989) (114)
- Liver X Receptor Agonists Inhibit Cytokine-Induced Osteopontin Expression in Macrophages Through Interference With Activator Protein-1 Signaling Pathways (2005) (112)
- Renin‐Angiotensin‐Aldosterone System in Diabetes and Hypertension (2011) (110)
- Liver X Receptor Agonists Suppress Vascular Smooth Muscle Cell Proliferation and Inhibit Neointima Formation in Balloon-Injured Rat Carotid Arteries (2004) (109)
- Therapeutic effect of calcium channel blockade in primary aldosteronism. (1985) (107)
- Coincident Linkage of Fasting Plasma Insulin and Blood Pressure to Chromosome 7q in Hypertensive Hispanic Families (2001) (106)
- Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. (2000) (96)
- Angiotensin II Induces Migration and Pyk2/Paxillin Phosphorylation of Human Monocytes (2001) (96)
- Genetic markers: progress and potential for cardiovascular disease. (2004) (95)
- Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance. (2005) (94)
- Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway (2005) (90)
- Human ovarian theca cells are a source of renin. (1988) (90)
- SORCS1: A Novel Human Type 2 Diabetes Susceptibility Gene Suggested by the Mouse (2007) (90)
- Heritability of Subclinical Atherosclerosis in Latino Families Ascertained Through a Hypertensive Parent (2002) (90)
- Rosiglitazone attenuates age‐ and diet‐associated nonalcoholic steatohepatitis in male low‐density lipoprotein receptor knockout mice (2010) (90)
- Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells (2004) (89)
- Response of experimental retinal neovascularization to thiazolidinediones. (2001) (89)
- Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation (2020) (88)
- Effects of sulindac and ibuprofen in patients with cirrhosis and ascites. An explanation for the renal-sparing effect of sulindac. (1986) (87)
- Changes in active and inactive renin throughout pregnancy. (1982) (86)
- Chronic insulin administration elevates blood pressure in rats. (1994) (86)
- Nuclear Factor (Erythroid-Derived 2)-Like-2 Factor (Nrf2), a Key Regulator of the Antioxidant Response to Protect Against Atherosclerosis and Nonalcoholic Steatohepatitis (2013) (85)
- Body Adiposity Index versus Body Mass Index and Other Anthropometric Traits as Correlates of Cardiometabolic Risk Factors (2013) (84)
- Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus (2014) (84)
- A Titrate‐to‐Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed‐Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide (2011) (80)
- Identification of renal cathepsin B as a human prorenin-processing enzyme. (1991) (79)
- Differential Roles of Cardiomyocyte and Macrophage Peroxisome Proliferator–Activated Receptor γ in Cardiac Fibrosis (2008) (78)
- Myeloid Deletion of Nuclear Factor Erythroid 2−Related Factor 2 Increases Atherosclerosis and Liver Injury (2012) (78)
- A Genome-Wide Scan for Carotid Artery Intima-Media Thickness: The Mexican-American Coronary Artery Disease Family Study (2005) (75)
- Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device (2021) (74)
- Critical role for osteopontin in diabetic nephropathy. (2010) (74)
- Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells. (2000) (74)
- Angiotensin II Enhances Integrin and α-Actinin Expression in Adult Rat Cardiac Fibroblasts (2000) (73)
- A Nuclear Receptor Corepressor–Dependent Pathway Mediates Suppression of Cytokine-Induced C-Reactive Protein Gene Expression by Liver X Receptor (2006) (73)
- TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. (1999) (72)
- Mechanical Unloading Promotes Myocardial Energy Recovery in Human Heart Failure (2014) (71)
- Mitogen-activated protein kinase activation mediates PDGF-directed migration of RPE cells. (1998) (71)
- PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4. (2002) (70)
- Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study). (2009) (69)
- Troglitazone inhibits angiotensin II‐induced DNA synthesis and migration in vascular smooth muscle cells (1997) (69)
- Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Mitogenic Induction of p21Cip1 by Modulating the Protein Kinase Cδ Pathway in Vascular Smooth Muscle Cells* (2001) (69)
- Integrins, adhesion, and cardiac remodeling. (1998) (68)
- Rosiglitazone Inhibits Acyl-CoA Synthetase Activity and Fatty Acid Partitioning to Diacylglycerol and Triacylglycerol via a Peroxisome Proliferator–Activated Receptor-γ–Independent Mechanism in Human Arterial Smooth Muscle Cells and Macrophages (2007) (67)
- Troglitazone inhibits angiotensin II‐induced extracellular signal‐regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells (1999) (66)
- Characterization of inactive renin from human kidney and plasma. Evidence of a renal source of circulating inactive renin. (1983) (65)
- Hypertension Genes are Genetic Markers for Insulin Sensitivity and Resistance (2004) (64)
- Inhibition of MAP kinase blocks insulin‐mediated DNA synthesis and transcriptional activation of c‐fos by Elk‐1 in vascular smooth muscle cells (1997) (63)
- Transcriptome analysis of human adipocytes implicates the NOD-like receptor pathway in obesity-induced adipose inflammation (2014) (63)
- Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor. (2012) (62)
- PPARgamma and atherosclerosis: effects on cell growth and movement. (2001) (61)
- Evidence of prostacyclin deficiency in the syndrome of hyporeninemic hypoaldosteronism. (1986) (60)
- Retinoids Inhibit Proliferation of Human Coronary Smooth Muscle Cells by Modulating Cell Cycle Regulators (2001) (59)
- Role of the lipoxygenase pathway in angiotensin II-mediated aldosterone biosynthesis in human adrenal glomerulosa cells. (1988) (59)
- Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 5: gender-related risk factors for ischemic heart disease. (2004) (58)
- Adipocyte adaptive immunity mediates diet-induced adipose inflammation and insulin resistance by decreasing adipose Treg cells (2017) (57)
- Comparison of ANG II with other growth factors on Egr-1 and matrix gene expression in cardiac fibroblasts. (1996) (56)
- Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome. (2014) (56)
- Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes (2006) (55)
- Glucose Tolerance and Insulin Action in Rats With Renovascular Hypertension (1991) (54)
- Human Prorenin (1991) (54)
- Freshly isolated mitochondria from failing human hearts exhibit preserved respiratory function. (2014) (54)
- BIG RENIN IN PLASMA OF HEALTHY SUBJECTS ON HIGH SODIUM INTAKE (1978) (54)
- Mechanism of Acid‐Activation of Renin: Role of Kallikrein in Renin Activation (1981) (53)
- Angiotensin II and αvβ3 Integrin Expression in Rat Neonatal Cardiac Fibroblasts (2000) (52)
- Evidence for Joint Genetic Control of Insulin Sensitivity and Systolic Blood Pressure in Hispanic Families With a Hypertensive Proband (2001) (51)
- Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells. (2001) (51)
- Characterization of pure human renal renin. Evidence for a subunit structure. (1987) (51)
- Extrarenal Renin‐Secreting Tumors: Insights into Hypertension and Ovarian Renin Production (1989) (50)
- Peroxisome proliferator-activated receptor-γ ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in Vascular smooth muscle cell migration (2001) (49)
- Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance. (2011) (49)
- Evidence for a Direct Vascular Effect (1995) (49)
- Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways. (2005) (48)
- Isometric exercise in patients with chronic advanced heart failure: hemodynamic and neurohumoral evaluation. (1985) (47)
- Vascular protective effects by activation of nuclear receptor PPARgamma. (2002) (47)
- Effect of aspirin on experimental diabetic nephropathy. (1987) (46)
- Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait. (2005) (45)
- Prediabetes: The Importance of Early Identification and Intervention (2010) (44)
- Reciprocal changes in active and inactive renin after converting enzyme inhibition in normal man. (1983) (44)
- Identification of an enzyme in human kidney that correctly processes prorenin. (1990) (44)
- Renin‐Angiotensin‐Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA (2018) (42)
- Determination and use of haplotypes: Ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans (2003) (41)
- Ovarian renin production in vitro and in vivo: characterization and clinical correlation. (1989) (41)
- The 3' untranslated region of the lipoprotein lipase gene: haplotype structure and association with post-heparin plasma lipase activity. (2005) (41)
- Metabolic and Antihypertensive Effects of Combined Angiotensin Receptor Blocker and Diuretic Therapy in Prediabetic Hypertensive Patients With the Cardiometabolic Syndrome (2008) (40)
- Increased fetoplacental active renin production in pregnancy-induced hypertension. (1987) (40)
- Systematic evaluation of validated type 2 diabetes and glycaemic trait loci for association with insulin clearance (2013) (39)
- Transcriptional Repression of ATP-Binding Cassette Transporter A1 Gene in Macrophages: A Novel Atherosclerotic Effect of Angiotensin II (2005) (39)
- Integrins αvβ3 and αvβ5 mediate VSMC migration and are elevated during neointima formation in the rat aorta (2001) (38)
- Uteroplacental unit as a source of elevated circulating prorenin levels in normal pregnancy. (1986) (38)
- Estrogen receptor alpha activation enhances mitochondrial function and systemic metabolism in high‐fat‐fed ovariectomized mice (2016) (38)
- PPAR and Atherosclerosis Effects on Cell Growth and Movement (2001) (38)
- Modifiable Lifestyle Risk Factors and Incident Diabetes in African Americans. (2017) (35)
- Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts. (2000) (34)
- Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells. (2000) (34)
- High-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance. (2013) (34)
- Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity. (2013) (33)
- Economic Benefits of Intensive Insulin Therapy in Critically Ill Patients (2008) (32)
- Activation and characterization of inactive big renin in plasma of patients with diabetic nephropathy and unusual active renin. (1980) (32)
- Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure. (1986) (32)
- Potential effects of renin activation on the regulation of renin production. (1984) (31)
- Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure. (1994) (31)
- Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes. (2006) (30)
- Adipocytes, Innate Immunity and Obesity: A Mini-Review (2021) (29)
- Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration. (2001) (29)
- Association of the diabetes gene calpain-10 with subclinical atherosclerosis: the Mexican-American Coronary Artery Disease Study. (2005) (29)
- A Peroxisome Proliferator-activated Receptor γ (PPARγ)/PPARγ Coactivator 1β Autoregulatory Loop in Adipocyte Mitochondrial Function* (2011) (29)
- Doxazosin inhibits retinoblastoma protein phosphorylation and G(1)-->S transition in human coronary smooth muscle cells. (2000) (29)
- MG53 Does Not Manifest the Development of Diabetes in db/db Mice (2020) (28)
- A comparison of cold and acid activation of big renin and of inactive renin in normal plasma. (1978) (28)
- Clusterin Impairs Hepatic Insulin Sensitivity and Adipocyte Clusterin Associates With Cardiometabolic Risk (2019) (27)
- Adiposity-Independent Effects of Aging on Insulin Sensitivity and Clearance in Mice and Humans (2019) (26)
- Diabetes is a vascular disease. (1998) (26)
- Angiotensin II promotes integrin-mediated collagen gel contraction by adult rat cardiac fibroblasts. (1999) (26)
- Upregulation of angiotensin II type 1 receptor gene expression in chronic renovascular hypertension. (1995) (26)
- Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway. (2005) (25)
- Insulin clearance: confirmation as a highly heritable trait, and genome-wide linkage analysis (2012) (25)
- The predictive role of blood glucose for mortality in subjects with cardiovascular disease. (2006) (25)
- Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells. (2001) (25)
- Effect of the renin-angiotensin system in the vascular disease of type II diabetes mellitus. (1992) (24)
- Type 2 Diabetes in the Elderly: Challenges in a Unique Patient Population (2016) (23)
- The Association of Estrogen Receptor‐&bgr; Gene Variation With Salt‐Sensitive Blood Pressure (2017) (23)
- Angiotensin II and alpha(v)beta(3) integrin expression in rat neonatal cardiac fibroblasts. (2000) (23)
- Central and renal hemodynamic effects and hormonal response to diltiazem in severe congestive heart failure. (1987) (22)
- TGF-β1 induces peroxisome proliferator-activated receptor γ1 and γ2 expression in human THP-1 monocytes (2002) (22)
- Plasma corticosteroids in hyperreninemic hypoaldosteronism: evidence for diffuse impairment of the zona glomerulosa. (1983) (22)
- Integrins alphavbeta3 and alphavbeta5 mediate VSMC migration and are elevated during neointima formation in the rat aorta. (2001) (21)
- Tumor Necrosis Factor α Inhibits Insulin-induced Mitogenic Signaling in Vascular Smooth Muscle Cells* (2000) (21)
- Telmisartan Effects on Insulin Resistance in Obese or Overweight Adults Without Diabetes or Hypertension (2010) (21)
- Biochemical Similarity of Expressed Human Prorenin and Native Inactive Renin (1986) (20)
- Genetic Effects on Obesity Assessed by Bivariate Genome Scan: The Mexican‐American Coronary Artery Disease Study (2006) (20)
- Doxazosin Inhibits Monocyte Chemotactic Protein 1–Directed Migration of Human Monocytes (2001) (19)
- Inactive Renin of High Molecular Weight (Big Renin) in Normal Human Plasma (1980) (19)
- Peroxisome proliferator-activated receptor-γ in the renal mesangium (2002) (18)
- Renin requires a structural alteration prior to activation by renal kallikrein. (1980) (18)
- Proximal 2.6 kb of 5'-flanking DNA is insufficient for human renin promoter activity in renin-synthesizing chorio-decidual cells. (1994) (18)
- Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from th (2011) (18)
- Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. (2003) (17)
- Gradients of prorenin and active renin in ovarian venous and peripheral venous blood samples obtained simultaneously. (1988) (16)
- Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis (2019) (16)
- Purification and characterization of human truncated prorenin. (1992) (16)
- Angiotensin II promotes remodelling-related events in cardiac fibroblasts. (1997) (16)
- Human Visceral Adipose Tissue Macrophages Are Not Adequately Defined by Standard Methods of Characterization (2019) (15)
- Introduction: New insight into understanding the relation of type 2 diabetes mellitus, insulin resistance, and cardiovascular disease. (2003) (14)
- Chemically induced renal hypertrophy in the rat. (1973) (14)
- Function of human renin proximal promoter DNA. (1994) (14)
- Evidence that the β-Adrenergic System and Prostaglandins Stimulate Renin Release through Different Mechanisms (1985) (14)
- Observations on the renal processing and sorting of prorenin. (1991) (14)
- Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome. (2013) (14)
- Obesogenic Memory Maintains Adipose Tissue Inflammation and Insulin Resistance (2020) (14)
- Role of cathepsin B as prorenin processing enzyme in human kidney. (1995) (14)
- Induced, but not natural, regulatory T cells retain phenotype and function following exposure to inflamed synovial fibroblasts (2020) (14)
- Adipocyte DIO2 Expression Increases in Human Obesity but Is Not Related to Systemic Insulin Sensitivity (2018) (14)
- of the National Heart , Lung , and Blood Institute – National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus (2005) (14)
- Mechanisms of hyperkalemia in systemic lupus erythematosus. (1988) (14)
- Insulin Clearance Is Associated with Hepatic Lipase Activity and Lipid and Adiposity Traits in Mexican Americans (2016) (13)
- Plasma cyclic guanosine monophosphate in chronic heart failure: Hemodynamic and neurohormonal correlations and response to nitrate therapy (1993) (13)
- Effect of des-Asp1-angiotensin II on secretion and metabolism of aldosterone. (1980) (13)
- Preventing heart failure in patients with diabetes. (2004) (13)
- Insulin resistance and macrovascular disease (1996) (13)
- PPAR-Gamma Effects on the Vasculature (2001) (12)
- Effect of plasma sodium concentration on diluting segment sodium reabsorption. (1974) (11)
- Classification of Type 2 Diabetes Genetic Variants and a Novel Genetic Risk Score Association with Insulin Clearance. (2019) (11)
- Differential effects of ramipril on ambulatory blood pressure in African Americans and Caucasians. (2007) (11)
- Effects of renin inhibition in systemic hypertension. (1990) (10)
- Effects on Cell Growth and Movement (2001) (10)
- Complete purification of human renal renin and sequence of the amino terminus. (1986) (10)
- Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk (2015) (10)
- Expression and Function of PPARg in Rat and Human Vascular Smooth Muscle Cells (2000) (9)
- Carotid intima-media thickness (cIMT) cosegregates with blood pressure and renal function in hypertensive Hispanic families. (2008) (9)
- Inactive renin in human plasma. Is it prorenin? (1982) (9)
- Familial factors in the antihypertensive response to lisinopril. (2001) (9)
- Vitamin A Deficiency in Patients Undergoing Sleeve Gastrectomy and Gastric Bypass: A 2-Year, Single-Center Review. (2019) (8)
- The Association of ARMC5 with the Renin-Angiotensin-Aldosterone System, Blood Pressure and Glycemia in African Americans. (2020) (8)
- Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy (2012) (8)
- Angiotensin II (AII) modulation of steroidogenesis by luteinized granulosa cells in vitro (1994) (8)
- Angiotensin II and cardiac remodeling. (1998) (8)
- Adrenocorticotropin-stimulated secretion of aldosterone and cortisol, computed from plasma and red blood cell measurements. (1979) (7)
- Synthesis and Collagen Gel Contraction (1996) (7)
- Loss of Antigen Presentation in Adipose Tissue Macrophages or in Adipocytes, but Not Both, Improves Glucose Metabolism (2019) (7)
- TGF-beta(1) induces peroxisome proliferator-activated receptor gamma1 and gamma2 expression in human THP-1 monocytes. (2002) (7)
- PPAR (cid:1) Inhibits TGF- (cid:2) –Induced (cid:2) 5 Integrin Transcription in Vascular Smooth Muscle Cells by Interacting With Smad4 (2002) (7)
- Treatment of type 2 diabetic nephropathy by blockade of the renin-angiotensin system: a comparison of angiotensin-converting-enzyme inhibitors and angiotensin receptor antagonists. (2002) (7)
- Peroxisome proliferator-activated receptor-gamma in the renal mesangium. (2002) (7)
- Association of Serum Aldosterone and Plasma Renin Activity With Ambulatory Blood Pressure in African Americans (2021) (7)
- Association of insulin sensitivity and glucose tolerance with the c.825C>T variant of the G protein beta-3 subunit gene. (2008) (6)
- Tumor necrosis factor alpha inhibits insulin-induced mitogenic signaling in vascular smooth muscle cells. (2000) (6)
- Multiorgan, Multimodality Imaging in Cardiometabolic Disease (2017) (6)
- Letter by Zhu et al Regarding Article, "Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis". (2019) (6)
- Insulin Expression and Glucose-Responsive Circulating C-Peptide in Type 1 Diabetes Patients Implanted Subcutaneously with Pluripotent Stem Cell-Derived Pancreatic Endoderm Cells in a Macro-Device (2019) (6)
- The pathophysiology of ovarian hyperstimulation syndrome (OHSS). A proposal role of the ovarian derived prorenin to angiotensin cascade (ODPAC). (1995) (6)
- Association between site‐specific bone mineral density and glucose homeostasis and anthropometric traits in healthy men and women (2018) (6)
- The Pathophysiology of Ovarian Hyperstimulation Syndrome (OHSS) (1995) (6)
- Inflammasomes and Obesity (2013) (6)
- Evidence that the beta-adrenergic system and prostaglandins stimulate renin release through different mechanisms. (1985) (6)
- Studies of the renal vasoactive systems in hyporeninemic hypoaldosteronism. (1981) (5)
- Studies comparing the metabolic clearance rate of 11 beta,17,21-trihydroxypregn-1,4-diene-3,20-dione (prednisolone) after oral 17,21-dihydroxypregn-1,4-diene-3,11,20-trione and intravenous prednisolone. (1979) (5)
- PPAR Inhibits TGF TGF TGF – Induced 5 Integrin Transcription in Vascular Smooth Muscle Cells by Interacting With Smad 4 (2002) (5)
- Expression and Function of Peroxisome Proliferator – Activated Receptor-g in Mesangial Cells (2001) (5)
- The role of the extrarenal renin‐angiotensin system (1992) (5)
- Adipose Tissue T Regulatory Cells: Implications for Health and Disease. (2021) (5)
- Diabetes mellitus, moderate renal insufficiency and hyperkalemia. (1983) (5)
- Interferon gamma mediates the reduction of adipose tissue regulatory T cells in human obesity (2022) (5)
- Genome-wide association study of body fat distribution traits in Hispanics/Latinos from the HCHS/SOL (2021) (5)
- CD4+CD126low/- Foxp3+ Cell Population Represents a Superior Subset of Regulatory T Cells in Treating Autoimmune Diseases. (2020) (5)
- The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects. (1989) (4)
- Molecular biology of human renin and its gene. (1991) (4)
- Pharmacological Treatment and Mechanisms of Insulin Resistance (1997) (4)
- Peroxisome Proliferator-activated Receptor Ligands Inhibit Mitogenic Induction of p 21 Cip 1 by Modulating the Protein Kinase C Pathway in Vascular Smooth Muscle Cells * (2001) (4)
- Gender-Related Risk Factors for Ischemic Heart Disease (2004) (4)
- A Dominant-Negative PPARγ Mutant Promotes Cell Cycle Progression and Cell Growth in Vascular Smooth Muscle Cells (2010) (4)
- PGC-1α: The Missing Ingredient for Mesenchymal Stem Cell–Mediated Angiogenesis (2012) (4)
- Peroxisome Proliferator-activated Receptor (cid:1) Ligands Inhibit Mitogenic Induction of p21 Cip1 by Modulating the Protein Kinase C (cid:2) Pathway in Vascular Smooth Muscle Cells* (2001) (3)
- Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome. (2005) (3)
- Characterization studies of inactive renin from human kidney and from several plasma sources. (1982) (3)
- MicroRNA-Integrated and Network-Embedded Gene Selection with Diffusion Distance (2010) (3)
- Obesity contributes to a dysfunctional regulatory T Cell phenotype within adipose tissue (2020) (3)
- Components of the Renin System (1983) (3)
- Ancestral diversity improves discovery and fine-mapping of genetic loci for anthropometric traits—The Hispanic/Latino Anthropometry Consortium (2021) (2)
- Physical Activity Associations with Bone Mineral Density and Modification by Metabolic Traits (2020) (2)
- Pharmacological treatment and mechanisms of insulin resistance. Impact on vascular smooth muscle cells, blood pressure, and lipids. (1997) (2)
- Low visceral adipose tissue regulatory T cells are associated with higher comorbidity severity in patients undergoing bariatric surgery (2020) (2)
- Insulin Resistance in Essential Hypertension (1991) (2)
- 816-4 Effect of glucose lowering on coronary circulatory dysfunction in type 2 diabetes mellitus (2004) (2)
- Association of Adiposity With Incident Diabetes Among Black Adults in the Jackson Heart Study (2021) (2)
- Proteases in hormone production and metabolism. (1984) (2)
- Class III obesity rather than metabolic syndrome impacts clinical outcomes of acute pancreatitis: A propensity score weighted analysis. (2020) (2)
- A Multinomial Ordinal Probit Model with Singular Value Decomposition Method for a Multinomial Trait. (2012) (2)
- The association of serum vitamin D with incident diabetes in an African American population (2022) (2)
- Adipocyte EGFL6 Expression from Subcutaneous Adipose Tissue Alters Glucose Homeostasis and Affects Human Obesity (2018) (2)
- In diabetes, treat hidden heart disease. (2000) (2)
- Differential Roles of Cardiomyocyte and Macrophage PPAR γ in Cardiac Fibrosis (2008) (2)
- IMPROVED GLUCOSE UTILIZATION AND MITOCHONDRIAL FUNCTION FOLLOWING LEFT VENTRICULAR ASSIST DEVICE SUPPORT (2010) (1)
- The Effect of Modified-Release Ketoconazole on Insulin Resistance in Patients with Severe Metabolic Syndrome (2012) (1)
- Monocytes Angiotensin II Induces Migration and Pyk 2 / Paxillin Phosphorylation of Human (2001) (1)
- Insulin resistance and hypertension. (1991) (1)
- Editorial: The Immunomodulatory Roles of Adipocytes (2021) (1)
- Mitochondrial Function is Preserved and Enhanced in Failing Human Myocardium: An Analysis of Paired Samples Obtained from Failing Right Ventricle (RV) and Normal Left Ventricle (LV) from Patients with PPH (2012) (1)
- Antihypertensive agents in diabetic patients: great benefits, special risks. (1999) (1)
- Blood Pressure and Insulin Resistance Cosegregate at Two Distinct Regions on Chromosome 7 (2000) (1)
- Renin in the female reproductive system. (1988) (1)
- Acute Reduction in Inactive Renin after Stimulation of Active Renin by Converting Enzyme Inhibition (CEI) in Man (1982) (1)
- Insulin-sensitizing thiazolidinedione improves coronary endothelial dysfunction in insulin resistance by PET measurements of myocardial blood flow (2002) (1)
- 795 Evidence for Restoration of Glucose Metabolism in Failing Myocardium Following Prolonged Mechanical Circulatory Support (2012) (0)
- Genome-wide association study of body fat distribution traits in Hispanics/Latinos from the HCHS/SOL Study (2021) (0)
- Abstract: 31 EZETIMIBE/SIMVASTATIN (E/S) VS ATORVASTATIN (A) IN METABOLIC SYNDROME (MS) PATIENTS WITH HYPERCHOLESTEROLEMIA (HC) (2009) (0)
- Growth effects of angiotensin II in the cardiovascular renal and reproductive systems (1994) (0)
- DB120078 979..980 (2012) (0)
- MicroPET imaging of myocardial insulin resistance in mice deficient of the cardiomyocyte PPAR{gamma} (2007) (0)
- Rosiglitazone Inhibits Acyl-CoA Synthetase Activity and Fatty Acid Partitioning to Diacylglycerol and Triacylglycerol via a PPAR γ-Independent Mechanism in Human Arterial Smooth Muscle Cells and Macrophages (2006) (0)
- Results Middle-Aged Mice Develop Worse Metabolic Syndrome in Response to HFD Than Young Mice (2009) (0)
- In Vivo Efficacy of Rosiglitazone-Loaded Hybrid Nanoparticles for the Treatment of Cardiovascular Diseases (2013) (0)
- Inhibit Neointima Formation in Balloon-Injured Rat Carotid Arteries Liver X Receptor Agonists Suppress Vascular Smooth Muscle Cell Proliferation and (2004) (0)
- Abstract 19172: Nanoparticle Delivery of Rosiglitazone Confers Tissue-Selective PPARgamma Activation (2012) (0)
- TATSUO SHINAGAWA*, YUNG S. Do*, JOHN D. BAXTERt, CYNTHIA CARILLIt, JAMES SCHILLINGt, (2016) (0)
- A novel method for testing association of multiple genetic markers with a multinomial trait. (2010) (0)
- The kidney in hypertension. Introduction. (1983) (0)
- CALPAIN-10: A GENETIC DETERMINANT OF BOTH DIABETES AND ATHEROSCLEROSIS.: 418 (2004) (0)
- Diabetes Mellitus: Cardiovascular Complications (2003) (0)
- Processing and sorting of human prorenin (1991) (0)
- Effect of Metabolic Syndrome Factors and Insulin Resistance on Ezetimibe/Simvastatin and Atorvastatin Treatment Efficacy in Patients with Metabolic Syndrome and Moderately High/High CHD Risk (2009) (0)
- Components of the renin system. An update. (1983) (0)
- Abstract 1474: Differential Roles of Cardiomyocyte and Macrophage PPAR{gamma} in Cardiac Fibrosis (2007) (0)
- Potentiation ofIsosorbide Dinitrate Effects WithN-Acetlcysteine inPatients With Chronic HeartFailure (1994) (0)
- Are Physical Activity Associations with Bone Mineral Density Modified by Metabolic Traits? (2018) (0)
- Dyslipidemia and Insulin Resistance in Nondiabetic Subjects with Fatty Liver Disease (2014) (0)
- The role of thiazolidinediones in reversing insulin resistance and altering coronary vasomotor function. (2005) (0)
- IS141 A II PROMOTES REMODELLING-RELATED EVENTS IN THE CARDIAC FIBROBLASTS (1997) (0)
- Pharmacologic treatment options for prediabetes (2008) (0)
- Chapter 2 Infl ammasomes and Obesity (2019) (0)
- Recent Advances in the Role of the Renal Nervous System and Renin in Hypertension (1987) (0)
- 1758-P: Alterations in Human Visceral Adipose Tissue Type 2 Innate Lymphoid Cells (ILC2s) with Aging: A Determinant of Insulin Resistance (2019) (0)
- Expression and Function of Peroxisome Proliferator–Activated Receptor-&ggr; in Mesangial Cells (2001) (0)
- Quantification of Retinal Vasculature in LDL Receptor Knockout Mice (2011) (0)
- Abstract: 582 ATTAINMENT OF SINGLE/DUAL TREATMENT LEVELS FOR LDL-C AND NON-HDL-C, APOB, OR HS-CRP IN PATIENTS WITH METABOLIC SYNDROME (MS): EZETIMIBE(E)/SIMVASTATIN(S) VS ATORVASTATIN(A) (2009) (0)
- Does Renin‐Angiotensin‐Aldosterone System Inhibition Impact Obesity as a Co–Risk Factor? (2009) (0)
- Abstract: P1308 EZETIMIBE/SIMVASTATIN (E/S) VS ATORVASTATIN (A) IN PATIENTS WITH HYPERCHOLESTEROLEMIA (HC) AND METABOLIC SYNDROME (METS) GROUPED BY PRESENCE OF ATHEROSCLEROTIC VASCULAR DISEASE (AVD) (2009) (0)
- 2010-P: Adipocyte Clusterin Is a Link between Cardiometabolism and Alzheimer’s Disease (2020) (0)
- A308 Changes in Adipocyte (Ad) Retinol Metabolism May be Associated with Reduced Adipose Tissue Regulatory T Cells (AT-Tregs) after Bariatric Surgery (2019) (0)
- Infl ammasomes and Obesity (2017) (0)
- Interaction of angiotensin II and interleukin 6 in adult rat cardiac fibroblasts (1999) (0)
- Influence of Age/Gender/Race on the Efficacy of Ezetimibe/Simvastatin vs. Atorvastatin in Metabolic Syndrome Patients with Moderately High/High CHD Risk (2009) (0)
- Abstract: P966 EFFECT OF AGE/GENDER/RACE ON EZETIMIBE/SIMVASTATIN VS. ATORVASTATIN EFFICACY IN METABOLIC SYNDROME PATIENTS WITH MODERATELY HIGH/HIGH CHD RISK (2009) (0)
- Abstract 3950: Deficiency of PPAR{gamma} in Cardiomyocytes Results in Myocardial Inflammation and Cardiac Insulin Resistance (2009) (0)
- PPARγ Expression and Function in Mesangial Cells: Implication for Renal Disease (2000) (0)
- Abstract: P947 EZETIMIBE/SIMVASTATIN (E/S) AND ATORVASTATIN (A) TREATMENT MODIFY APOB, LDL-C, AND NON-HDL-C CORRELATIONS IN METABOLIC SYNDROME (MS) PATIENTS AT MODERATELY HIGH RISK(MHR)/HIGH RISK(HR) FOR CHD (2009) (0)
- Peroxisome Proliferator–Activated Receptor-&ggr; Ligands Inhibit Nuclear but Not Cytosolic Extracellular Signal–Regulated Kinase/Mitogen–Activated Protein Kinase–Regulated Steps in Vascular Smooth Muscle Cell Migration (2001) (0)
- Adiposity-Independent Effects of Aging on Insulin Sensitivity and Clearance in Humans and Mice (2018) (0)
- 1675-P: Adipocyte Adaptive Immune Cell Function and Exhaustion Contribute to the Drop in Adipose Tissue (AT) Regulatory T-Cells (Tregs) in Human Obesity (2020) (0)
- Abstract 003: The Impact of MHCII Loss in Myeloid Cells and Adipocytes on Atherosclerosis and Liver Fat Accumulation (2018) (0)
- Actions of Angiotensin II on Isolated Cardiac Fibroblasts (1998) (0)
- Abstract P057: Optimal Modifiable Lifestyle Risk Factor Scores Are Associated with Lower Risk of Type 2 Diabetes Mellitus in African Americans - The Jackson Heart Study (2017) (0)
- Lifestyle Interventions to Treat Prediabetes (2015) (0)
- Doxazosin Inhibits MCP-1 Directed Migration of Human Monocytes (2000) (0)
- Angiotensin II Induces Human Monocyte Migration and Pyk2/ Paxillin Phosphorylation (2000) (0)
- Osteopontin Deficiency Attenuates Tubulointerstitial Injury in Angiotensin II‐Infused Mice. (2008) (0)
- The Kidney in Hypertension (1983) (0)
- Abstract 19466: Metabolomic and Gene Expression Changes in End-Stage Heart Failure are Reversed by Left Ventricular Assist Device (2012) (0)
- Chronic Traumatic Encephalopathy : The Neuropathological Legacy of Traumatic Brain Injury (2016) (0)
- PPAR&agr; Inhibits TGF-&bgr;–Induced &bgr;5 Integrin Transcription in Vascular Smooth Muscle Cells by Interacting With Smad4 (2002) (0)
- P-632: Angiotensin II accelerates macrophage lipid accumulation via suppression of ATP-binding cassette transporter A1 (2005) (0)
- 90-OR: High-Fat Diet Acutely Decreases Adipose Immunosuppressive T Regulatory Cells Leading to Insulin Resistance (2019) (0)
- Asians , Insulin Resistance , and PPAR Gamma (2002) (0)
- Retinoid Ligands Inhibit Cell Proliferation by Modulating Cell Cycle Regulators in Human Coronary Smooth Muscle Cells (2000) (0)
- Complicated hypertension patients-diabetes and insulin resistance (1998) (0)
- Age, Abdominal Obesity, and Baseline High-Sensitivity C-Reactive Protein Are Associated with Low-Density Lipoprotein Cholesterol, non–High-Density Lipoprotein Cholesterol, and ApoB Responses to Lipid-Lowering Therapy in Patients with Metabolic Syndrome and Moderately High/High Coronary Heart Disease (2012) (0)
- Characterization of inflammatory changes in the breast cancer associated adipose tissue and comparison to the unaffected contralateral breast. (2021) (0)
- The value of PPAR agonists in relation to endothelial function (2007) (0)
- Abstract: P967 INFLUENCE OF METABOLIC SYNDROME (MS) FACTORS AND INSULIN RESISTANCE (IR) ON EZETIMIBE (E)/SIMVASTATIN (S) AND ATORVASTATIN (A) EFFICACY IN PATIENTS WITH MS AND MODERATELY HIGH (MH) OR HIGH (H) CHD RISK (2009) (0)
- Angiotensin converting enzyme inhibition in the prevention of ovarian hyperstimulation syndrome (OHSS): A proposal for the role of the ovarian derived prorenin to angiotensin cascade (ODPAC) (1994) (0)
- Evolving Concepts in Diabetes and the Metabolic Syndrome (2016) (0)
- A. N. Richards Symposium (1991) (0)
- The role of thiazolidinediones in reversing insulin sensitivity and altering endothelial dysfunction (2005) (0)
- The use of thiazolidinedione agents in post cardiac transplant diabetic patients (2004) (0)
- Efficacy and Safety of Ezetimibe/Simvastatin vs. Atorvastatin in Patients with Hypercholesterolemia, Metabolic Syndrome, and Atherosclerotic Vascular Disease (2009) (0)
- Workshop on Diagnosis and Treatment of Cardiac Maladaptive Remodeling (1999) (0)
- Rosiglitazone improves characteristics of Non‐Alcoholic Steatohepatitis (NASH) in a mouse model of metabolic syndrome (2010) (0)
- Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications (2023) (0)
- The association of aldosterone and endothelin-1 with incident diabetes among African Americans: The Jackson Heart Study (2023) (0)
- Effect of a synthetic prostacyclin analogue on renin release in man. (1986) (0)
- 1417-P: Gut Microbiome Translocation to Visceral Adipose Tissue Promotes Recruitment of Adipose-Specific Neutrophils in Human Obesity (2022) (0)
- Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk (2015) (0)
- Erratum: Ancestral diversity improves discovery and fine-mapping of genetic loci for anthropometric traits-The Hispanic/Latino Anthropometry Consortium. (2023) (0)
- Peroxisome proliferator-activated receptor gamma activation reverses adipose tissue regulatory T cell dysfunction. (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Willa Ann Hsueh?
Willa Ann Hsueh is affiliated with the following schools:
